Molecular Diagnostic Tests:
Molecular diagnostic tests are a sub-segment of the enteric disease testing market that utilizes nucleic acid detection techniques to identify and detect pathogens causing gastrointestinal infections. These tests provide highly accurate and rapid results, allowing for timely and effective treatment. The increasing prevalence of enteric diseases worldwide and the advantages offered by molecular diagnostic tests, such as higher sensitivity and specificity, are driving the growth of this segment.
The enteric disease testing market is highly competitive, with several key players leading the market. Some of the prominent players in the market include:
1. Bio-Rad Laboratories, Inc.
2. Meridian Bioscience, Inc.
3. Thermo Fisher Scientific Inc.
4. Quidel Corporation
5. Alere Inc.
6. bioMérieux SA
7. F. Hoffmann-La Roche AG
8. Cepheid Inc.
9. DiaSorin Molecular LLC
10. Luminex Corporation
These players are focusing on strategic partnerships, acquisitions, and new product launches to strengthen their market position. Additionally, the development of innovative technologies and the investment in research and development activities are helping these companies to stay competitive in the market.